Skip to main content
Clinical Trials/NCT05023876
NCT05023876
Completed
Not Applicable

Effect of Instrument Assisted Soft Tissue Mobilization in Chronic Obstructive Pulmonary Disease

Okan University1 site in 1 country30 target enrollmentMarch 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Okan University
Enrollment
30
Locations
1
Primary Endpoint
Respiratory Function
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of this study is to investigate the effect of instrument-assisted soft tissue mobilization applied to the hamstring muscle on respiratory function in patients with COPDThe patients to be included in the study will be divided into two groups by simple randomization. A group will be given breathing exercises (pursed lip breathing, diaphragmatic breathing and thoracic expansion exercises) as a home program. The other group will be given breathing exercises in the form of a home program in addition to 1 session of EDYM per week. Both groups will be evaluated before and 4 weeks after treatment.

Registry
clinicaltrials.gov
Start Date
March 14, 2022
End Date
September 28, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Okan University
Responsible Party
Principal Investigator
Principal Investigator

Emine Atıcı

Principal Investigator

Okan University

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with GOLD stage I-II COPD
  • Between the ages of 40-65
  • COPD in stable period
  • No other respiratory disease that impairs respiratory functions such as asthma
  • Knee flexion angle of 15 degrees and above in the hamstring muscle shortness test,
  • Individuals without musculoskeletal problems in their lower extremities were included.

Exclusion Criteria

  • COPD patients who receive home oxygen therapy or who need oxygen therapy frequently
  • COPD exacerbation, hospitalization with acute exacerbation in the last 15 days
  • Pregnancy
  • Kyphoscoliosis, advanced postural disorder
  • Prior thoracic surgery
  • Advanced heart failure
  • Patients with primary pulmonary hypertension or have had a pulmonary embolism,
  • Having serious neurological diseases such as Parkinson's, hemiplegia, multiple sclerosis,
  • Neuromuscular disease
  • Having dementia, Alzheimer's or advanced cognitive problems,

Outcomes

Primary Outcomes

Respiratory Function

Time Frame: 5 minute

Respiratory Function evaluated with spirometer

Secondary Outcomes

  • Chest circumference measurement(5 minute)
  • Popliteal angle test(3 minutes)
  • Finger-floor distance measurement(3 minutes)
  • Hand grip strength(3 minutes)
  • 6-minute walk test(6 minute)

Study Sites (1)

Loading locations...

Similar Trials